|
|
Diabetes Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Diabetes Therapeutic, including, but not limited to market trend on Dialysis; Monitoring; Insulin; Oral Hypoglycemics and therapeutic of: Dyslipidemia; Diabetic Complications.
We offer market research, industry forecasts, and business analysis in the Diabetes Therapeutic as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Insulin Delivery Systems Market Analysis (2008-2012) |
|
| Table of Contents Published: 2009/08 Published by: RNCOS E-Services Pvt. Ltd. |
| The report provides extensive information and rational analysis on the global insulin market as well as insulin delivery methods. Thus, it provides valuable information to pharmaceutical and biotech companies and investors looking to enter this market. An ... |
| Adult Obesity and Diabetes - US - August 2009 |
|
| Table of Contents Published: 2009/08 Published by: Mintel International Group Ltd, |
| More than 150 million adults in the US are overweight or obese, and this affects businesses in diverse categories, including food service, supermarkets, airlines, healthcare, and weight loss. ... |
| Global Diabetes Market |
|
| Table of Contents Published: 2009/06 Published by: Frost & Sullivan |
| This research services details the market drivers, restraints, challenges, revenue forecasts of the insulin and the no-insulin market segments of the global diabetes market. It also deals with regional analysis of the US, Europe, Japan and rest of the wor ... |
| Chinese Markets for Diabetes Drugs |
|
| Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co. |
| China' s demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, suppl ... |
| Diabetes, Metabolic Syndrome and Cardiovascular Disease |
|
| Table of Contents Published: 2009/04 Published by: Trimark Publications |
| There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly ... |
| Blood Glucose Testing and Diabetes Management |
|
| Table of Contents Published: 2009/04 Published by: Trimark Publications |
| There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly ... |
| The Toolkit for Diabetes MSL Programs |
|
| Table of Contents Published: 2009/03 Published by: Cutting Edge Information |
| Currently, about 246 million people worldwide have diabetes; this number is expected to increase to 380 million by 2025, according to the International Diabetes Foundation. Such staggering figures solidify diabetes' position as a primary therapeutic area. ... |
| World Diabetes Market Analysis, 2009-2023 |
|
| Table of Contents Published: 2009/02 Published by: Visiongain |
| This visiongain report - World Diabetes Market Analysis, 2009-2023 - provides in-depth analysis of the markets for insulins, insulin analogues and oral anti-diabetics. This report also covers the new GLP-1 analogues - such as Byetta and liraglutide - as w ... |
| Exubera Case Study: Misjudging the Market |
|
| Table of Contents Published: 2009/02 Published by: Best Practices, LLC |
| This case study reviews the failed strategy and tactics utilized by Pfizer for the launch of its inhaled insulin product Exubera for diabetes. The study reviews the pharma giant' s missteps with payers, consumers and KOLs as it launched the product. Pfize ... |
| Diabetes Drug Discoveries 2009: what the future holds |
|
| Table of Contents Published: 2009/02 Published by: Espicom Business Intelligence |
| This strategic report from Espicom puts the spotlight on current and future drugs that will be used in the treatment of Type I and Type II diabetes, providing industry and investors with a comprehensive overview of the market in the medium term. ... |
| CV & Diabetes Market Forecast |
|
| Table of Contents Published: 2009/01 Published by: Datamonitor |
| Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2017. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of ... |
| China: Anti-Diabetic Drug Market Report 2008 |
|
| Table of Contents Published: 2009/01 Published by: Draco Healthcare Consulting, LLC |
| When China started its economic reform in 1978, the diabetes disease rate was about 0.6% in the Chinese population. As China entered the rapid growth phase of its economic development, the diabetes disease rate has arisen rapidly. In 1995, the diabetes di ... |
| European Diabetes Diagnostics Market |
|
| Table of Contents Published: 2008/12 Published by: Frost & Sullivan |
| This strategic analysis service provides a detailed analysis of the European diabetes diagnostics market. An in-depth analysis of marketing parameters (revenues, forecasts, geographic trends and market share) coupled with competitive factors and strategie ... |
| Competitor Analysis: Emerging Diabetes Drugs |
|
| Table of Contents Published: 2008/11 Published by: La Merie |
| The Competitive Intelligence Report Emerging Diabetes Drugs & Targets as of November 2008 provides a competitor analysis in the development pipeline of novel emerging antidiabetic treatment modalities for type 1 and 2 diabetes beyond the established targe ... |
| Diabetes Drug Pipeline |
|
| Table of Contents Published: 2008/11 Published by: La Merie |
| The Competitive Intelligence Report Diabetes Drug Pipeline as of November 2008 provides a competitor analysis in the development pipeline of novel antidiabetic treatment modalities for type 1 and 2 diabetes. The report includes an overview of the major ma ... |
| Brands & Strategies: Lipid-Modifying Agents |
|
| Table of Contents Published: 2008/11 Published by: Decision Resources, Inc. |
| The lipid-modifying drug market is highly competitive, currently comprising at least 14 brands in seven major drug classes, and extremely lucrative, with major-market sales surpassing $24 billion in 2007. However, we forecast sales to decline by 4% annual ... |
| Stakeholder Opinions: Diabetic Renal Disease |
|
| Table of Contents Published: 2008/11 Published by: Datamonitor |
| Prevalence of diabetic renal disease is on the rise. Current treatment focuses on the management of hypertension and glycemic control, but is unable to address the deterioration of renal function. An unmet need exists for therapies fully reversing disease ... |
| Diabetes Market Forecast to 2013 |
|
| Table of Contents Published: 2008/11 Published by: Cutting Edge Information |
| CEI' s veteran analysts answer these questions - and more - by placing critical drug information in a relevant industry-wide context. Other reports skim the surface, examining only top drugs at top companies. Ours is complete, covering marketed brands, pi ... |
| Glucose Testing Markets |
|
| Table of Contents Published: 2008/11 Published by: Kalorama Information |
| This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present. The rep ... |
| Competitor Analysis: Insulin |
|
| Table of Contents Published: 2008/10 Published by: La Merie |
| The next generations of insulin will be tailored insulin and oral insulin. Tailored insulin analogs and other long-acting insulins for injection with drug delivery solutions aim at optimized pharmacokinetic profiles in order to avoid hyper- and hypo-glyce ... |
| Blood Glucose Meters and Strips |
|
| Table of Contents Published: 2008/10 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Blood Glucose Meters and Strips in Millions of US$. The specific product segments analyzed are Blood Glucose Strips, and Blood Glucose Meters. The report provides separate comprehensive analytics for the US, ... |
| Mexican Diabetes Therapy Market |
|
| Table of Contents Published: 2008/10 Published by: Frost & Sullivan |
| Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and p ... |
|
| Autoimmune Drug Focus (ADF) |
|
| Issues / Year: 12 Published by: Espicom Business Intelligence |
| Do you want to keep up-to-date with all the latest developments in this important and high-value pharmaceutical area? Autoimmune Drug Focus (ADF) provides a simple, time-saving way to do just that. It summarises all the latest developments in an easy-to-r ... |
| The Diabetes Report |
|
| Table of Contents Issues / Year: 12 Published by: Espicom Business Intelligence |
| The number of people with diabetes has reached epidemic proportions, with the International Diabetes Federation currently stating that it is the fourth main cause of death in most developed countries. ... |
|
|
|
View Cart
